Metraipolis › archive › dc_9db4a2a2d95c
Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer — Europe PMC PMID:39216661
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39216661
- DOI
- 10.1016/j.mcpro.2024.100834
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T10:01:59.603Z
- SHA-256 of the archived text
ce17fb6eeb0ec046ced65a807fee4a8a3557c39fb557e203e144f6320b6bf7d3- Stable URL of this page
https://metraipolis.com/documento/dc_9db4a2a2d95c
How to cite
Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer — Europe PMC PMID:39216661 — Europe PMC (en), https://europepmc.org/article/MED/39216661 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9db4a2a2d95c (Metraipolis archive dc_9db4a2a2d95c, sha256 ce17fb6eeb0ec046ced65a807fee4a8a3557c39fb557e203e144f6320b6bf7d3)
BibTeX
@misc{dc9db4a2a2d95c,
title = {Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer — Europe PMC PMID:39216661},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39216661},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9db4a2a2d95c; sha256 ce17fb6eeb0ec046ced65a807fee4a8a3557c39fb557e203e144f6320b6bf7d3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39216661. Agents can read the archived copy with the MCP tool read_document.